G. Steven Burrill
An introduction to Burrill Venture Capital
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech takes a beating in market meltdown October 01, 2008 | Press Release
Biotech outperforms market in May June 02, 2008 | Press Release
Biotech Treads Water in April May 01, 2008 | Press Release
See all NewsVenture Capital
Catalyst Biosciences is developing the next generation of biopharmaceuticals by harnessing the catalytic power of proteases. Proteases are naturally occurring protein-degrading enzymes that regulate a wide variety of biological processes. Catalyst is harnessing the power of these enzymes as bio-pharmaceuticals by redirecting them to degrade specific proteins that promote disease.
Website: http://www.catbio.com